Sandi Peterson

J&J Pharmaceutical Success Drives Increase In 2014 Forecast
Sandra "Sandi" Peterson, group worldwide chairman of Johnson & Johnson (J&J), stands for a photograph at the J&J consumer healthcare products plant in Lititz, Pennsylvania, U.S., on Wednesday, June 18, 2014. Johnson & Johnson, the world's biggest health-care products company, beat expectations in its first-quarter earnings release in April and raised its 2014 forecast by focusing on new drugs and reducing its reliance on medical devices. J&J is expected to release second-quarter earnings figures on July 15. Photographer: Andrew Harrer/Bloomberg via Getty ImagesBloomberg via Getty Images
  • Rank
  • Previous Rank
  • Age
  • Title
  • Company
  • Industry

Peterson is in her second year leading consumer-facing businesses, which include brands like Tylenol and Listerine. She has responsibility for $20 billion in revenue and some 70,000 people--more than half of J&J's total workforce.